3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Colorectal Neoplasms
131
Colonic Neoplasms
72
Rectal Neoplasms
61
Breast Neoplasms
61
Stomach Neoplasms
37
Pancreatic Neoplasms
31
Squamous Cell Carcinoma of Head and Neck
27
Esophageal Neoplasms
24
Head and Neck Neoplasms
23
Neoplasm Metastasis
22
Esophageal Squamous Cell Carcinoma
16
Carcinoma, Hepatocellular
16
Adenocarcinoma Of Esophagus
16
Parkinson Disease 4, Autosomal Dominant Lewy Body
14
Neoplasms
11
Nasopharyngeal Carcinoma
11
Adenocarcinoma
7
Urinary Bladder Neoplasms
5
Keratosis, Actinic
5
Cholangiocarcinoma
5
Anus Neoplasms
5
Intestinal Neoplasms
4
Inflammatory Breast Neoplasms
4
Hepatoblastoma
4
Gastrointestinal Neoplasms
4
Digestive System Neoplasms
4
Biliary Tract Neoplasms
4
Laryngeal Neoplasms
3
Hypopharyngeal Neoplasms
3
HIV Infections
3
Interventions
human papillomavirus vaccine, L1 type 16, 18
22
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
15
Papillomavirus Vaccines
9
Vaccines
6
Blood Specimen Collection
4
Watchful Waiting
2
Vaccines, Synthetic
2
Light Coagulation
2
Hepatitis A Vaccines
2
Engerix-B
2
lime
1
halofantrine
1
Sodium Chloride
1
Radiotherapy, Intensity-Modulated
1
Pentetic Acid
1
Olive Oil
1
Observation
1
Measles-Mumps-Rubella Vaccine
1
Laser Therapy
1
Injections
1
Imiquimod
1
Human Papillomavirus DNA Tests
1
Fluorouracil
1
Diphtheria-Tetanus-acellular Pertussis Vaccines
1
DTPa-HBV-IPV combined vaccine
1
Colposcopy
1
Clinical Protocols
1
Cisplatin
1
Circumcision, Male
1
Chorionic Villi Sampling
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Papillomavirus Infections
×
Fluorouracil
×
Clear all
NCT02135419
2024-07-26
ANCHOR
AIDS Malignancy Consortium
Phase 3
Completed
4,446 enrolled
13 charts